UPM Q3 2026 — strong cash flow amid destocking and rising variable costs

Key highlights
  • Q3 sales were €2,202 million and comparable EBIT €131 million, a comparable EBIT margin of 5.9%, down 8% year‑on‑year.
  • Operating cash flow in Q3 was €420 million following working‑capital efficiency actions; net debt at end‑September was €2,993 million (net debt/EBITDA 2.09).
  • Leuna biorefinery reached RFF production readiness and will produce qualification volumes in Q4; integrated production is now expected to start in Q2 2027 with nominal capacity in early 2028.
  • UPM’s Plywood business is being demerged into WISA Group to list on Nasdaq Helsinki in November, while the planned graphic‑paper joint venture with Sappi is under renewed EU Commission scrutiny.
Related project For subscribers
Milestones, plant data, involved companies (owners, investors, licensors, contractors) and news — kept up to date.
Commissioning & Start-up
2020-01-30
2020-01-30
2020-10
2024-10
Operational / Completed · expected date for subscribers

Quarter results

Continuing operations reported Q3 sales of €2,202 million and comparable EBIT of €131 million (5.9% margin), with performance weighed down by customer destocking and higher variable costs. Year‑to‑date comparable EBIT rose 10% to €601 million, improving the margin to 8.6%.

Cash flow and balance sheet

Actions to improve working‑capital efficiency produced strong operating cash flow of €420 million in Q3 (€645 million for Q1–Q3). Net debt decreased to €2,993 million and net debt/EBITDA improved to 2.09. The company reiterated disciplined capital allocation and dividend payments (first 2025 installment paid in April: €395 million).

Operations and assets

Decarbonization solutions (UPM Energy, UPM Biofuels) performed strongly; Advanced Materials and Fibres were stable overall though some units faced destocking and curtailments. Communication Papers experienced weaker demand and margin pressure, underpinning rationale for the planned JV with Sappi. The Leuna biorefinery has achieved two core processes in production and RFF readiness; integrated sugars‑to‑glycols production will start around Q2 2027, with nominal capacity in early 2028.

Strategic moves, outlook and sensitivities

The Plywood business is presented as discontinued ahead of the WISA Group listing in November. The Sappi JV is progressing but faces EU competition concerns. UPM expects H2 2026 comparable EBIT from continuing operations of approximately €375–575 million. Sensitivities: a €50/tonne pulp price change impacts annual comparable EBIT by ~€180–270 million; a €10/MWh electricity price change affects annual comparable EBIT by ~€40 million.

Source: UPM

chemXplore Weekly

The week’s project milestones and project news from the chemical industry, free every Wednesday.

Free. One email a week. Unsubscribe any time. See our Privacy Policy.

Related articles

15 October 2026
UPM opens Leuna biorefinery for wood-based renewable chemicals

World’s largest lignocellulosic biorefinery with 220,000 t/yr capacity converts beechwood and sawmill residues into industrial sugars and lignin for renewable chemicals and fuels.

23 July 2026
UPM H1 2026: Q2 EBIT up 71%; plywood demerger approved and graphic paper JV agreed

Q2 comparable EBIT rose 71% to €212m; portfolio moves include a graphic paper joint venture and approved demerger of the plywood unit.

19 December 2025
UPM's Leuna Biorefinery Begins Commercial Production of Bio-based Chemicals

The biorefinery produces industrial sugars, enabling renewable glycols and lignin fillers, supporting the shift from fossil to bio-based materials, with full operations expected by 2026.

11 December 2025
UPM Unveils Bio-Based, NIR-Detectable, Carbon-Negative Pigment for Packaging

UPM's new pigment, derived from lignin, offers recyclability and a carbon-negative footprint, addressing black packaging's recycling challenges and supporting sustainable packaging solutions.

17 June 2025
UPM Leuna Biorefinery Earns Triple Sustainability Certification

The biorefinery uses certified sustainable wood to produce biochemicals, supporting responsible sourcing and brand trust, with production starting in late 2025.